Eiger BioPharmaceuticals Inc (EIGRQ)

[Fezziwig2008]

EIGR “IFN-Lambda4 showed a strong therapeutic effect in reducing MERS-CoV infection with higher induction of IFN-stimulated genes. Thus, IFN-? has a decisive function in the respiratory epithelium that greatly limits MERS-CoV replication, and may be a key cytokine for better therapeutic outcomes against MERS-CoV infection in respiratory tract.” Success w/1 coronavirus is Promising-awaiting word from Stanford on interim dat in SARS-2 by summer’s end.

https://scholar.google.com/scholar?start=10&q=interferon+lambda&hl=en&as_sdt=0,33&as_ylo=2020#d=gs_qabs&u=%23p%3DG9p7gPGYVVwJ